在瘤-骨科研究中的证据水平 - ACTA ORTOP BRAS (1993-2022)
Alex Guedes1, Ângelo Rebouças Fernandes Curvelo Sousa1, Marco Aurélio Santos Santana2
1Grupo de Oncologia Ortopédica, Hospital Santa Izabel, Santa Casa de Misericórdia da Bahia, Salvador, BA, Brazil.
Acta ortopedica brasileira
|November 4, 2024
概括
这项研究分析了从1993年到2022年在Acta Ortopédica Brasileira中进行的瘤和骨科研究. 虽然大多数研究的证据水平 (LE) 较低,但随着时间的推移,证据质量发生了积极的演变.
科学领域:
- 整形外科手术 整形外科手术
- 在瘤学瘤学.
- 医学研究方法学 医学研究方法学
背景情况:
- 巴西骨科医学杂志 (Acta Ortopédica Brasileira) 是巴西骨科研究的一个重要期刊.
- 瘤-骨科研究是骨科文献中一个特定但重要的子领域.
- 了解已发表研究的证据基础对于临床实践和未来研究设计至关重要.
研究的目的:
- 识别和分类30年来在巴西骨科医学杂志上发表的瘤和骨科研究.
- 评估这些研究分类的证据水平 (LE) 和评审者间的协议.
- 分析研究期间该领域证据质量的演变.
主要方法:
- 对1993年至2022年间发表的瘤-骨科研究进行了回顾性分析.
- 根据类型和证据水平 (LE) 分类研究的分类.
- 统计分析包括评价者间协议 (卡帕统计) 和与出版期的关联.
主要成果:
- 在1349篇论文中,69篇 (5.1%) 被确定为瘤-骨科研究.
- 研究类型,统计方法和LE与出版期之间发现了显著的关联 (p < 0.05).
- 在LE分类方面,达成了高度的互评级协议 (92.8%).
结论:
- 瘤-骨科研究构成了杂志出版物中很小但很重要的部分.
- 大多数研究 (80%) 最初的证据水平较低 (NE IV和V).
- 在过去的三十年中,观察到向更高水平的证据 (LE II,III和IV) 的积极趋势,表明研究质量的进化.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


